Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma

Osteosarcoma (OS) is the second most common cause of cancer-related death in pediatric patients. The insulin-like growth factor (IGF) pathway plays a relevant role in the biology of OS but no IGF targeted therapies have been successful as monotherapy so far. Here, we tested the effect of three IGF s...

Descripción completa

Detalles Bibliográficos
Autores principales: Beck, Olaf, Paret, Claudia, Russo, Alexandra, Burhenne, Jürgen, Fresnais, Margaux, Steimel, Kevin, Seidmann, Larissa, Wagner, Daniel-Christoph, Vewinger, Nadine, Lehmann, Nadine, Sprang, Maximilian, Backes, Nora, Roth, Lea, Neu, Marie Astrid, Wingerter, Arthur, Henninger, Nicole, El Malki, Khalifa, Otto, Henrike, Alt, Francesca, Desuki, Alexander, Kindler, Thomas, Faber, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225940/
https://www.ncbi.nlm.nih.gov/pubmed/32224911
http://dx.doi.org/10.3390/cancers12040793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225940/
https://www.ncbi.nlm.nih.gov/pubmed/32224911
http://dx.doi.org/10.3390/cancers12040793

Ejemplares similares